Search

everythinglearnresearchcommunity

for

Search:↓

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Using dermoscopy to guide scalp biopsies is an effective way to diagnose cicatricial alopecia.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Different factors help diagnose and treat hair loss accurately.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Hair loss in autoimmune blistering skin diseases varies and may regrow with disease control.

Certain micronutrients may improve hair and nail health, but more research is needed to confirm their benefits.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Early life factors, including a mother's health and environment, can affect the chances of developing polycystic ovary syndrome later in life.

Many pediatric epilepsy patients experience preventable severe adverse drug reactions, especially with certain medications and risk factors.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

COVID-19 may cause increased hair loss, but the exact reason is unclear and standard hair loss treatments are recommended.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

The document concludes that hair restoration has advanced significantly, with FUE becoming more popular, and stresses the importance of physician training and ethical practices in the field.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Pediatric dermatologists need to understand the unique skin health needs of LGBTQIA youth to provide better care.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

COVID-19 can cause various skin issues, with some linked to how severe the illness is.

YH0618 helped reduce skin and nail problems and fatigue in chemotherapy patients.

Syphilis has a wide range of symptoms that can look like other diseases, and if not treated, it can progress to a more serious stage, especially in HIV-positive patients.